Clinical Implications of IL-32, IL-34 and IL-37 in Atherosclerosis: Speculative Role in Cardiovascular Manifestations of COVID-19.

MLA

Law, Ching Chee, et al. “Clinical Implications of IL-32, IL-34 and IL-37 in Atherosclerosis: Speculative Role in Cardiovascular Manifestations of COVID-19.” Frontiers in Cardiovascular Medicine, vol. 8, Aug. 2021, p. 630767. EBSCOhost, https://doi.org/10.3389/fcvm.2021.630767.

APA

Law, C. C., Puranik, R., Fan, J., Fei, J., Hambly, B. D., & Bao, S. (2021). Clinical Implications of IL-32, IL-34 and IL-37 in Atherosclerosis: Speculative Role in Cardiovascular Manifestations of COVID-19. Frontiers in Cardiovascular Medicine, 8, 630767. https://doi.org/10.3389/fcvm.2021.630767

Chicago

Law, Ching Chee, Rajesh Puranik, Jingchun Fan, Jian Fei, Brett D Hambly, and Shisan Bao. 2021. “Clinical Implications of IL-32, IL-34 and IL-37 in Atherosclerosis: Speculative Role in Cardiovascular Manifestations of COVID-19.” Frontiers in Cardiovascular Medicine 8 (August): 630767. doi:10.3389/fcvm.2021.630767.